BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
SIRT1
,
Angiogenesis
,
Hepatitis
,
Prostate
,
Anticancer prodrugs
,
Fenofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
glycosphingolipid catabolic process
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Microglial cell
Small intestine
Lung
Colon
Ileum mucosa
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Stachybotryotoxicosis
Toxic effect of mycotoxin
Fibrosis of lung
Methicillin resistant Staphylococcus aureus infection
Gaucher's disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Chemokine CCL17
Exotoxins
verteporfin
IL17F protein, human
indole
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
EPOP
dpy-9
SELENOF
STAR
EZR
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Mammary epithelial 3134 cell line with induced dominant negative BRG1, CHD4 or SNF2H overexpression
Spontaneous transformation of murine kidney and bladder epithelial cells
Myoblast C2C12 cells (differentiated and quiescent) with PRDM2 shRNA knockdown
Embryonic stem cells derived from normal fertilization and parthenogenesis
Glioblastoma cells from MYC[T58A] DN-TP53 mice treated with panobinostat
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for glycosphingolipid catabolic process
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Enzyme Replacement Therapy in Fabry Disease
Myocardial Affectation in Patients With Fabry Disease Without Phenotypic Manifestation. Diagnostic V…
Fabry Disease in Cerebrovascular Disease
Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ